• Biomarker commercialization tools (BIC Tools) support and guide the highly regulated and strict development phases of the in-vitro diagnostics (IVD) applicable biomarker development process
• Tools are intended for academic researchers, SMEs, and technology transfer organizations (TTOs) and are available at biomarker.nu
• BIC Tools cover clinical, regulatory, and business aspects of the commercialization process

The life science industry is going through a technological transition. In the future, new innovations are expected in areas where individualized medical science, elderly care, digital services, genetics, and preventive health care meet. Here, biomarkers play a crucial role.

“We are happy to announce that the Best Practices and Pitfalls in Commercializing IVD-Applicable Biomarkers Handbook is now available from biomarker.nu webpage. The handbook is the first of four biomarker commercialization tools that are being published this summer by the Biomarker Commercialization (BIC) project consortium with the objective of bringing new and better IVD-applicable biomarkers more efficiently from discovery into clinical use”, tells the main author of the handbook, Dr. Piia von Lode, Innovation Manager at the University of Turku, Finland.

Miten bioteknologinen keksintö kaupallistetaan ja miksi keksintöjen kaupallistaminen on tärkeää? Aiheesta keskustelevat Pekka Simula (Suomen Bioteollisuus, pj.) ja Sebastian Soidinsalo (Spark Finland).